Magnus Persson

Insider Reports History

Entity
Individual
Location
400 E. Pratt Street, Suite 606, Baltimore, MD
Signature
/s/ Christopher Sullivan, by Power of Attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Magnus Persson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Avalo Therapeutics, Inc. Director Stock Option (Right to Buy) 3.33K Dec 20, 2023 Direct

Insider Reports Filed by Magnus Persson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVTX Avalo Therapeutics, Inc. Dec 20, 2023 1 $0 4 Dec 21, 2023 Director
AVTX Avalo Therapeutics, Inc. Jun 30, 2023 1 $0 4 Jul 5, 2023 Director
AVTX Avalo Therapeutics, Inc. Mar 31, 2023 1 $0 4 Apr 4, 2023 Director
AVTX Avalo Therapeutics, Inc. Dec 30, 2022 1 $0 4 Jan 3, 2023 Director
AVTX Avalo Therapeutics, Inc. Sep 30, 2022 1 $0 4 Oct 3, 2022 Director
AVTX Avalo Therapeutics, Inc. Jun 30, 2022 1 $0 4 Jul 5, 2022 Director
AVTX Avalo Therapeutics, Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
AVTX Avalo Therapeutics, Inc. Mar 31, 2022 1 $0 4 Apr 4, 2022 Director
AVTX Avalo Therapeutics, Inc. Dec 31, 2021 1 $0 4 Jan 4, 2022 Director
AVTX Avalo Therapeutics, Inc. Sep 30, 2021 1 $0 4 Oct 4, 2021 Director
AVTX Cerecor Inc. Jun 30, 2021 1 $0 4 Jul 2, 2021 Director
AVTX Cerecor Inc. Jun 15, 2021 1 $0 4 Jun 17, 2021 Director